Ranbaxy Laboratories after market hours on Tuesday, 29 October 2013, reported consolidated net loss of Rs 454.16 crore in Q3 September 2013, compared with net profit of Rs 754.17 crore in Q3 September 2012. Total income increased 1.92% to Rs 2827.73 crore in Q3 September 2013 over Q3 September 2012.
Ranbaxy Laboratories said that the depreciation of the rupee against the dollar, though favourable to Ranbaxy's export business had an adverse impact on the company mainly on account of application of the accounting standards that require marking to market the entire derivatives and foreign currency denominated loans outstanding. There was a charge of Rs 360 crore during Q3 September 2013 on account of foreign exchange fluctuations, Ranbaxy said. The company made a provision for Mohali stock write-off and other costs amounting to Rs 70 crore.
Ranbaxy said that its base business sales in Q3 September 2013 continued to grow over the corresponding period of the previous year. Ranbaxy's global sales rose 2.99% to Rs 2750 crore in Q3 September 2013 over Q3 September 2012. The growth in sales was impacted adversely by the new pricing policy and trade concerns in India and the absence of any post exclusivity sales during the quarter, Ranbaxy said.
Commenting on the business results for the quarter, Mr. Arun Sawhney, CEO & Managing Director, Ranbaxy, said: "The company continues to grow in its focus branded markets in Asia, East Europe, CIS and Africa. In India, however, the announcement of the pricing policy caused some uncertainty in the market, during which our sales in the home market faced some disruptions. We are confident that we will satisfactorily address the increasing standards of quality and manufacturing processes to uphold the high level of trust that our doctors, patients, regulators and other stakeholders expect from us."
The board of directors of the company have decided to change the financial year of the company as "April to March" effective 1 April 2014. In view of this, the current financial year will be for a period of 15 months i.e. January 2013 to March 2014.
Ranbaxy said it expects to achieve sales of Rs 13000 crore to Rs 13500 crore for 15 months period ending 31 March 2014. This does not consider any sales accruing from FTFs which shall be accounted for as they materialize.
More From This Section
NTPC after market hours on Tuesday, 29 October 2013, reported 20.66% fall in net profit to Rs 2492.90 crore on 0.64% fall in total income to Rs 17059.41 crore in Q2 September 2013 over Q2 September 2012.
Bharti Airtel, DLF, Lupin, Nestle India, Grasim Industries and Jindal Steel & Power announce their Q2 results today, 30 October 2013.
Tata Steel said its long products business has proposed restructuring to help strengthen its competitiveness. The proposed changes affect predominately management and administrative functions at sites in Scunthorpe, Teesside and Workington and could lead to the loss of around 500 jobs. About 340 positions could be affected in Scunthorpe, 90 in Workington and 40 in Teesside. The proposals come amid a prolonged downturn in demand for some of the key products made by the Scunthorpe-based business, including the UK market for construction steel, which is about half of 2007 levels, Tata Steel said in a statement.
The European operations of Tata Steel comprise Europe's second largest steel producer. With the main steelmaking operations in the UK and Netherlands, they supply steel and related services to the construction, automotive, packaging, rail, lifting & excavating, energy & power, aerospace and other demanding markets worldwide.
Real estate developer Brigade Enterprises' net profit rose 28.2% to Rs 19.02 crore on 12.7% decline in net sales to Rs 135.21 crore in Q2 September 2013 over Q2 September 2012.
Separately, Brigade Enterprises annnounced signing a deal with InterContinental Hotels Group (IHG) to build 10 Holiday Inn Express 3-star brand hotels in South India, which will be owned by Brigade Group and managed by IHG. The first two hotels under this partnership will open in Bangalore in 2017, while the remaining eight hotels are scheduled to open before 2020. Brigade Group and IHG are currently in partnership for the Holiday Inn - Tidel Park on Old Mahabalipuram Road (OMR), Chennai. The hotel is scheduled to open in early 2015. Brigade said the newly-signed hotels will add to its existing hospitality portfolio of 6 hotels across South India, both operational and in different stages of development.
Bank of Maharashtra said its board has decided to raise upto Rs 800 crore through preferential allotment of equity shares to the Government of India.
On a consolidated basis, Tata Communications reported net profit of Rs 80.36 crore in Q2 September 2013 compared with net loss of Rs 274.24 crore in Q2 September 2012. Net sales rose 16% to Rs 4952.61 crore in Q2 September 2013 over Q2 September 2012.
On a consolidated basis, Jubilant Life Sciences reported net loss of Rs 80.58 crore in Q2 September 2013 compared with net profit of Rs 152 crore in Q2 September 2012. Net sales rose 17.8% to Rs 1424.30 crore in Q2 September 2013 over Q2 September 2012.
Commenting on the Company's performance, Mr. Shyam S Bhartia, Chairman & Managing Director and Mr. Hari S Bhartia, Co-Chairman & Managing Director, Jubilant Life Sciences said: "Our performance is shaped by good volumes traction in Q2 FY2014. Growth will accelerate in H2 on the back of product launches under Solid Dosage Formulations, scale up in Speciality Pharmaceuticals and volume uptick visible in Vitamins and Acetyl businesses due to higher capacity utilisation levels. FY2014 will be marked by a strong business performance from all key business verticals and the restructuring initiative aimed at de-leveraging the balance sheet, which will drive a focussed reduction in debt."
ALSTOM India's net profit fell 49% to Rs 27.84 crore on 20.2% fall in net sales to Rs 590.04 crore in Q2 September 2013 over Q2 September 2012.
Symphony's net profit surged 598.54% to Rs 14.32 crore on 196.50% surge in net sales to Rs 72.08 crore in Q2 September 2013 over Q2 September 2012.
Mangalore Refinery and Petrochemicalss net profit declined 80.11% to Rs 235.77 crore on 15.04% rise in net sales to Rs 18762.33 crore in Q2 September 2013 over Q2 September 2012.
Jai Corp's net profit rose 9.1% to Rs 23.39 crore on 2.2% increase in net sales to Rs 171.24 crore in Q2 September 2013 over Q2 September 2012.
Separately, Jai Corp said its board has decided to redeem 3.75 lakh fully paid-up 1% non-cumulative, non-participating redeemable preference shares.
Powered by Capital Market - Live News